Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: Results from a randomized trial

Transfusion

Volumn 52, Issue 3, 2012, Pages 470-477

  Rombout Sestrienkova, Eva ^a,b,c,d   Nieman, Fred H M ^a,b,c,d   Essers, Brigitte A B ^a,b,c,d   Van Noord, Paulus A H ^a,b,c,d   Janssen, Mirian C H ^a,b,c,d   Van Deursen, Cees Th B M ^a,b,c,d   Bos, Laurens P ^a,b,c,d   Rombout, Ferdinand ^a,b,c,d   Van Den Braak, Rogier ^a,b,c,d   De Leeuw, Peter W ^a,b,c,d   Koek, Ger H ^a,b,c,d  

^a Sanquin Blood Supply ^*  (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; CYTAPHERESIS; ERYTHROCYTAPHERESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; INTERMETHOD COMPARISON; IRON OVERLOAD; MALE; PHLEBOTOMY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; BLOOD COMPONENT REMOVAL; ERYTHROCYTES; FEMALE; HEALTH CARE COSTS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, CARDIOVASCULAR; PHLEBOTOMY; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84858244108     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03292.x     Document Type: Article

References (30)

1. Adams PC, Barton JC,. How I treat hemochromatosis. Blood 2010; 116: 317-25.
2. Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, Loréal O,. Current approach to hemochromatosis. Blood Rev 2008; 22: 195-210.
3. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV,. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998; 129: 932-9.
4. Swinkels DW, Jorna AT, Raymakers RA,. Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis. Neth J Med 2007; 65: 452-5.
5. Niederau C, Stremmel W, Strohmeyer GW,. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994; 7: 881-901.
6. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G,. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19. (Pubitemid 26113751)
7. Mc Donnel S, Preston B, Jewel SA, Barton JC, Edwards CQ, Adams PC, Yip R,. A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999; 106: 619-25.
8. Mc Donnel S, Grindon A, Preston B, Barton J, Edwards C, Adams PC,. A survey of phlebotomy among persons with hemochromatosis. Transfusion 1999; 39: 651-6. (Pubitemid 29275337)
9. Brissot P, Ball S, Rofail D, Cannon H, Jin VW,. Hereditary hemochromatosis: patient experience of the disease and phlebotomy treatment. Transfusion 2010; 51: 1331-8.
10. Wijermans P, van Egmond L, Ypma P, Kerkhoffs JL, Schipperus M, Bohmer L, Agteresch E,. Isovolemic erythrocytapheresis technique as an alternative to conventional phlebotomy in patients with polycythemia rubra vera and hemochromatosis. Transfus Apher Sci 2009; 40: 137.
11. Conte D, Brunelli L, Bozzani A, Tidone L, Quatrini M, Bianchi PA,. Erythrocytapheresis in idiopathic haemochromatosis. Br Med J (Clin Res Ed) 1983; 286: 939. (Pubitemid 13152764)
12. Zoller WG, Kellner H, Spengel FA,. Erythrocytapheresis. A method for rapid extracorporeal elimination of erythrocytes. Results in 65 patients. Klin Wochenschr 1988; 66: 404-9.
13. Rombout-Sestrienkova E, van Noord PA, van Deursen CT, Sybesma BJ, Nillesen-Meertens AE, Koek GH,. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis-A pilot study. Transfus Apher Sci 2007; 36: 261-7. (Pubitemid 47089103)
14. Rombout-Sestrienkova E, Noord PA, Reuser E, Heeremans J, Deursen CT, Janssen M, Koek GH,. Therapeutic Erythrocytapheresis (TE) versus Phlebotomy (P) in the treatment of Hereditary Hemochromatosis (HH) patients: preliminary results from an ongoing randomized clinical trial (NCT 00202436). Transfus Apher Sci 2009; 40: 135-6.
15. Muncunill J, Vaquer P, Galmes A, Obrador A, Parera M, Bargay J, Besalduch J,. In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy. J Clin Apheresis 2002; 17: 88-92. (Pubitemid 34809557)
16. Mariani R, Pelucchi S, Perseghin P, Corengia C, Piperno A,. Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage. Haematologica 2005; 90: 717-8. (Pubitemid 40780906)
17. Kohan A, Niborski R, Daruich J, Rey J, Bastos F, Amerise G, Herrera R, Garcia M, Olivera W, Santarelli MT, Avalos JS, Findor J,. Erythrocytapheresis with recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative. Vox Sang 2000; 79: 40-5.
18. Kellner H, Zoller WG,. Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis. Z Gastroenterol 1992; 30: 779-83. (Pubitemid 23008795)
19. Fernandez-Mosteirin N, Salvador-Osuna C, Garcia-Erce JA, Orna E, Perez-Lungmus G, Giralt M,. Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations. Med Clin (Barc) 2006; 127: 409-12. (Pubitemid 44682648)
20. Conte D, Mandelli C, Cesana M, Ferrini R, Marconi M, Bianchi A,. Effectiveness of erythrocytapheresis in idiopathic hemochromatosis. Report of 14 cases. Int J Artif Organs 1989; 12: 59-62. (Pubitemid 19036800)
21. Barton JC,. Optimal management strategies for chronic iron overload. Drugs 2007; 67: 685-700. (Pubitemid 46535643)
22. Rabin R, de Carro F,. EQ-5D: a measure of health status from the Euro Qol Group. Ann Med 2001; 33: 337-43. (Pubitemid 32675374)
23. Oostenbrink JB, Bouwmans CA, Koopmanschap MA, Rutten FF,. Handleiding voor kostenonderzoek, methoden en standard kostprijzen voor economische evaluaties in de gezondheidszorg. Geactualiseerde versie. Diemen: College voor zorgverzekeringen; 2004.
24. Koopmanschap MA, Rutten FA, van Ineveld BM, van Roijen L,. The friction cost method for measuring indirect costs of disease. J Health Econ 1999; 14: 171-89.
25. Efron B, Tibshirani RJ,. An introduction to the bootstrap. London: Chapman & Hall; 1993.
26. Hicken BL, Tucker DC, Barton JC,. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol 2003; 98: 2072-7. (Pubitemid 37185808)
27. Wiltbank T, Giordano G,. The safety profile of automated collections: an analysis of more than 1 million collections. Transfusion 2007; 47: 1002-5. (Pubitemid 46802077)
28. Popovsky MA,. Complications of blood donation: manual and automated blood collection procedures. Transfus Med Hemother 2004; 31: 49-53. (Pubitemid 38253127)
29. Popovsky MA,. Safety of RBC apheresis and whole blood donation in allogenic and autologous blood donors. Transfus Apher Sci 2006; 34: 205-11.
30. Gold MR, Siegel JE, Russell LB, Weinstein MC,. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.